Benzinga
Benzinga
Benzinga
samedi, septembre 26

Ardent Health Inc

ARDTNYSE
Trade with Public
Trade with Public
$10.54
0.060.57%
À la clôture: Sep 25, 5:00 PM EST
$10.54
N/A
Après les heures: 4:00 PM EST
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentActionnariatComparerOptionsRapport sur les stocks

Ardent Health Financials

Ardent Health (ARDT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Ardent Health Lowers FY2026 GAAP EPS Guidance from $0.90-$1.27 to $0.78-$1.15 vs $1.09 Est; Affirms FY2026 Sales Guidance of $6.400B-$6.700B vs $6.441B Est

Ardent Health (NYSE:ARDT) lowers FY2026 GAAP EPS guidance from $0.90-$1.27 to $0.78-$1.15 vs $1.09 analyst estimate. Affirms FY2026 sales outlook from $6.400 billion-$6.700 billion to $6.400 billion-$6.700 billion vs
Benzinga Newsdesk

PRO
Ardent Health Partners Q2 EPS $0.12 Misses $0.19 Estimate, Sales $1.622B Beat $1.590B Estimate

Ardent Health Partners (NYSE:ARDT) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.19 by 36.84 percent. This is a 76.92 percent decrease over earnings of $0.52 per share
Benzinga Newsdesk

PRO
Ardent Health Reaffirms FY26 Adj EBITDA Guidance Of $485M-$535M

Commenting on the Company's financial outlook, Alfred Lumsdaine, Chief Financial Officer, said "During the second quarter, we've observed volume softness across our portfolio. We have taken appropriate and decisive
Benzinga Newsdesk

PRO
Ardent Health Affirms FY2026 GAAP EPS Guidance of $0.90-$1.27 vs $1.13 Est; Affirms FY2026 Sales Guidance of $6.400B-$6.700B vs $6.567B Est

Ardent Health (NYSE:ARDT) affirms FY2026 GAAP EPS guidance from $0.90-$1.27 to $0.90-$1.27 vs $1.13 analyst estimate. Affirms FY2026 sales outlook from $6.400 billion-$6.700 billion to $6.400 billion-$6.700 billion vs
Benzinga Newsdesk

PRO
Ardent Health Partners Q1 EPS $0.28 Beats $0.20 Estimate, Sales $1.601B Beat $1.582B Estimate

Ardent Health Partners (NYSE:ARDT) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $0.20 by 40 percent. This is a 3.45 percent decrease over earnings of $0.29 per share from
Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved